Press release
Corneal Edema Market in the US Projected for Significant Expansion from ~USD 489 Million in 2022 | DelveInsight
DelveInsight's latest report, "Corneal Edema: Market Insights, Epidemiology, and Market Forecast-2034 [https://www.delveinsight.com/report-store/corneal-edema-us-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]" combines robust epidemiological data with corneal edema market trends, competitive landscape analysis, and patient journey assessments. The report forecasts that the market for corneal edema in the US is expected to grow positively from ~USD 489 million in 2022 over the coming years. This growth is attributed to improved diagnostic capabilities, a rising aging population contributing to an increase in corneal edema patient population, and the emergence of new and effective corneal edema treatments during the forecast period.
The report also provides an in-depth epidemiological analysis and forecasts until 2034, segmented by total diagnosed prevalent cases of corneal edema, etiology-specific corneal edema diagnosed prevalent cases, and total treatable corneal edema cases in the US.
According to research conducted by DelveInsight's analysts, the total diagnosed prevalence of corneal edema is approximately 1.18 million in 2023. The corneal edema diagnosed prevalent cases are further categorized based on mechanical, dystrophic, and inflammatory causes.
Discover evolving trends in Corneal Edema patient pool forecasts-Download sample report on Corneal Edema Epidemiology 2034 Analysis [https://www.delveinsight.com/sample-request/corneal-edema-us-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr] now!
The current treatment approach for corneal edema is dynamic and involves a tailored strategy based on the underlying cause and severity of the condition. Initial management often includes hypertonic saline solutions or hyperosmotic agents to reduce inflammation and draw excess fluid from the cornea. In cases where the corneal endothelium is severely compromised, surgical interventions or laser procedures, such as Selective Laser Trabeculoplasty (SLT), may be considered, particularly in cases associated with secondary glaucoma.
The treatment gap in corneal edema lies primarily in the absence of a universally effective and minimally invasive therapy that addresses the underlying causes and reverses the condition instead of focusing on managing symptoms or replacing damaged corneal tissue.
DelveInsight's analysis reveals that a decent number of companies are launching clinical trials to address this unmet need in the corneal edema treatment landscape. The clinical development pipeline includes drugs such as EO2002 (Emmetrope Ophthalmics LLC), TTHX1114 (Trefoil Therapeutics), GLANATEC (D. Western Therapeutics Institute (DWTI)/Kowa Ltd.), AURN001 (Aurion Biotech) and STN1010904 (Santen Pharmaceutical), among others which are expected to enter the market during the forecast period and going to impact the trajectory of corneal edema market.
Unlock which corneal edema emerging drug is expected to capture the largest market share in 7MM by 2034 market, visit Corneal Edema Market Insights [https://www.delveinsight.com/sample-request/corneal-edema-us-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]
In December 2024, AURN001, an allogeneic cell therapy by Aurion Biotech showed positive results in Phase 1/2 trials for the US market. EO2002, a nonsurgical cell therapy by Emmetrope Ophthalmics LLC demonstrated improvement in best-corrected visual acuity (BCVA) during a Phase 1 extension study as of November 2024. These developments highlight the momentum in this field.
Although corneal edema presents significant challenges, particularly due to the difficulty of early-stage detection, which can lead to ineffective management and increased severity, the emergence of more precise and sensitive diagnostic methods, along with novel therapies, is expected to expand treatment options and drive market growth.
Download the report to understand which factors are driving Corneal Edema market trends @ Corneal Edema Market Trends [https://www.delveinsight.com/sample-request/corneal-edema-us-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr].
Table of Contents
1.
Key Insights
2.
Report Introduction
3.
Corneal Edema Market Overview at a Glance
3.1.
Market Share (%) Distribution by Therapies of Corneal Edema in 2020
3.2.
Market Share (%) Distribution by Therapies of Corneal Edema in 2034
4.
Epidemiology and Market Methodology of Corneal Edema
5.
Executive Summary of Corneal Edema
6.
Key Events
7.
Corneal Edema: Disease Background and Overview
7.1.
Introduction
7.2.
Etiology
7.3.
Pathophysiology
7.4.
Diagnosis
7.4.1.
Differential Diagnosis
7.4.2.
Diagnostic Algorithm
7.4.3.
Diagnostic Guidelines
7.4.3.1.
American Academy of Ophthalmology (AAO) 2018 Guideline for Corneal Edema and Opacification Preferred Practice Pattern
7.5.
Management
7.5.1.
Treatment Algorithm
7.5.2.
Treatment Guidelines
7.5.2.1.
AAO 2018 Guideline for Corneal Edema and Opacification Preferred Practice Pattern
8.
Corneal Edema Epidemiology and Patient Population
8.1.
Key Findings
8.2.
Assumptions and Rationale
8.2.1.
Etiology-specific Diagnosed Prevalent Cases of Corneal Edema
8.3.
The United States
8.3.1.
Total Diagnosed Prevalent Cases of Corneal Edema in the US
8.3.2.
Etiology-specific Diagnosed Prevalent Cases of Corneal Edema in the US
9.
Corneal Edema Patient Journey
10.
Corneal Edema Emerging Drugs
10.1.
Key Cross Competition
10.2.
EO2002: Emmetrope Ophthalmics LLC ("Emmecell")
10.2.1.
Product Description
10.2.2.
Other Development Activities
10.2.3.
Clinical Development
10.2.4.
Clinical Trial Information
10.2.5.
Safety and Efficacy
10.2.6.
Product Profile
10.2.7.
Analysts' Views
10.3.
TTHX1114: Trefoil Therapeutics
10.3.1.
Product Description
10.3.2.
Other Developmental Activities
10.3.3.
Clinical Development
10.3.4.
Clinical Trials Information
10.3.5.
Safety and Efficacy
10.3.6.
Product Profile
10.3.7.
Analyst Views
10.4.
GLANATEC (ripasudil/K-321): D. Western Therapeutics Institute (DWTI)/Kowa Ltd.
10.4.1.
Product Description
10.4.2.
Other Development Activities
10.4.3.
Clinical Development
10.4.4.
Clinical Trial Information
10.4.5.
Product Profile
10.4.6.
Analysts' Views
10.5.
STN1010904 (sirolimus)/AE001: Santen Pharmaceutical/ Actual Eyes
10.5.1.
Product Description
10.5.2.
Other Developmental Activities
10.5.3.
Clinical Development
10.5.4.
Clinical Trials Information
10.5.5.
Product Profile
10.5.6.
Analyst Views
11.
Corneal Edema: Market Analysis
11.1.
Key Findings
11.2.
Corneal Edema Market Outlook
11.3.
Conjoint Analysis
11.4.
Key Market Forecast Assumptions
11.5.
Total Market Size of Corneal Edema in the US
11.6.
Market Size of Corneal Edema by Therapies in the US
12.
Key Opinion Leaders' Views
13.
SWOT Analysis
14.
Corneal Edema Unmet Needs
15.
Market Access and Reimbursement
15.1.
The United States
15.1.1.
Center for Medicare and Medicaid Services (CMS)
16.
Appendix
16.1.
Bibliography
16.2.
Acronyms and Abbreviations
16.3.
Report Methodology
17.
DelveInsight Capabilities
18.
Disclaimer
Related Reports
Fuchs Endothelial Corneal Dystrophy Pipeline Insight [https://www.delveinsight.com/report-store/fuchs-endothelial-corneal-dystrophy-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]
Fuchs Endothelial Corneal Dystrophy Pipeline Insight provides comprehensive insights about the Fuchs Endothelial Corneal pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the Fuchs Endothelial Corneal companies, including Trefoil Therapeutics, Kowa Pharmaceutical and Santen Pharmaceutical
Media Contact
Company Name: DelveInsight
Contact Person: Arpit Anand
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=corneal-edema-market-in-the-us-projected-for-significant-expansion-from-usd-489-million-in-2022-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Corneal Edema Market in the US Projected for Significant Expansion from ~USD 489 Million in 2022 | DelveInsight here
News-ID: 3899550 • Views: …
More Releases from ABNewswire
Bedrock Restoration - Water Fire Mold Damage Service, Expands Water Damage Repai …
Water Fire Mold Damage Service, a trusted provider of property restoration, has announced expanded service offerings to meet the growing demand for professional water damage solutions in the region. Known for their reliable, customer-focused approach, the company continues to support both homeowners and businesses in recovering from unexpected property damage caused by water, fire, or mold.
Responding to a Growing Need for Water Damage Restoration
Property owners across Minnesota are increasingly seeking…
Winkler Kurtz LLP Expands Resources to Handle Increased Demand for Personal Inju …
For individuals searching for personal injury attorneys, the expansion of Winkler Kurtz LLP's team means greater accessibility and reduced wait times for consultations. The firm's deep roots in the Port Jefferson Station community allow them to understand local nuances, such as common accident hotspots and specific regional legal precedents.
Port Jefferson Station has seen a notable rise in personal injury cases, driven by factors such as increased traffic congestion, construction activity,…
Protecting Property Value: Hose Bros Inc Highlights How Professional Power Washi …
For residents searching for power washing near me, Hose Bros Inc offers accessible and reliable services tailored to the Millsboro community. Their local expertise ensures an understanding of regional challenges, such as the impact of salt air on coastal properties or the tendency for humidity to promote mold growth in shaded areas. This knowledge allows them to customize their approach, selecting appropriate pressure levels and cleaning agents for different surfaces.
In…
![Tampa Bay Home Remodeling Costs Guide [2025] Kitchen & Bathroom Renovation Prices](https://cdn.open-pr.com/9/1/914818326_g.jpg)
Tampa Bay Home Remodeling Costs Guide [2025] Kitchen & Bathroom Renovation Price …
A 2025 cost guide to kitchen, bathroom, and full home remodeling in Tampa Bay, featuring expert insights from Craftline Remodeling on pricing, budgeting, and contractor selection.
Market Overview: Understanding Tampa Bay Remodeling Investment Trends
Tampa Bay's home remodeling market has experienced significant cost evolution in 2025, with project expenses varying dramatically across South Tampa, Carrollwood, Seminole Heights, Clearwater, St. Petersburg, and Wesley Chapel based on material choices, project scope, and contractor expertise.…
More Releases for Corneal
Evolving Market Drivers In The Corneal Topographers Industry: Rising Prevalence …
The Corneal Topographers Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Corneal Topographers Market Size During the Forecast Period?
The corneal topographers market has grown strongly in recent years. It will grow from $0.88 billion in 2024 to $0.93 billion in 2025,…
Corneal Topographers Market Insights, Forecast to 2033
The new report published by The Business Research Company, titled Corneal Topographers Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the corneal topographers market size has grown strongly in recent years. It will grow from $0.83 billion in 2023…
Corneal Topographers Market A Clearer View of Corneal Disease: How Corneal Topog …
Corneal Topographers Market
Corneal Topographers Market to reach over USD 1,051.91 Million by the year 2031 - Exclusive Report by InsightAce Analytic
"Corneal Topographers Market" in terms of revenue was estimated to be worth USD 738.36 Million in 2023 and is poised to reach USD 1,051.91 Million by 2031, growing at a CAGR of 4.65% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for free Sample Pages:…
Artificial Corneal and Corneal Implant Market 2022 Industry Key Player, Trend an …
SDKI Inc. aims to provide a detailed analysis of several aspects of the market, including market growth drivers, opportunities, recent trends and challenges between 2021 and 2026. The artificial corneal and corneal implant market.
Report sample URL
https://www.sdki.jp/sample-request-112023
The global artificial corneal and corneal implant market is estimated to reach US $ 599 million by 2026 from US $ 418 million in 2021 and is projected to grow at a CAGR of 7.4%…
Global Corneal Pachymetry Market Research Report 2017
Report Hive Market Research Released a New Research Report of 110 pages on Title " Global Corneal Pachymetry Market Research Report 2017 "with detailed Analysis, Forecast and Strategies.
Corneal pachymetry is the way toward measuring the thickness of the cornea. A pachymeter is a restorative gadget used to gauge the thickness of the eye's cornea. It is utilized to perform corneal pachymetry preceding refractive surgery, for Keratoconus screening, LRI surgery and…
Corneal Neovascularization Market: Current trends/opportunities/challenges
Global Corneal Neovascularization Market: Outlook
Corneal neovascularization is a disorder of the eyes, which is mainly characterized by the incursion of novel blood vessels into the cornea of the individuals suffering from the disease. This disorder is majorly caused due to disruption of the balance between the factors that protects and maintain the corneal transparency. The two factors that need to be balanced include angiogenic and antiangiogenic factors. The incursion of…
